Kiniksa Pharmaceuticals
KNSA
KNSA
159 hedge funds and large institutions have $772M invested in Kiniksa Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 61 increasing their positions, 58 reducing their positions, and 34 closing their positions.
Holders
159
Holders Change
-16
Holders Change %
-9.14%
% of All Funds
2.12%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.01%
New
19
Increased
61
Reduced
58
Closed
34
Calls
$2.39M
Puts
$2.41M
Net Calls
-$24K
Net Calls Change
-$618K
Top Buyers
| 1 |
B
1
Braidwell
Stamford,
Connecticut
|
$68.3M |
| 2 |
2
Morgan Stanley
New York
|
$29.4M |
| 3 |
3
JPMorgan Chase & Co
New York
|
$9.45M |
| 4 |
4
Acadian Asset Management
Boston,
Massachusetts
|
$7.56M |
| 5 |
5
Millennium Management
New York
|
$15.4M |
